Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1

Jeffrey T. Safrit, Ruth Ruprecht, Flavia Ferrantelli, Weidong Xu, Moiz Kitabwalla, Koen Van Rompay, Marta Marthas, Nancy Haigwood, John R. Mascola, Katherine Luzuriaga, Samuel Adeniyi Jones, Bonnie J. Mathieson, Marie Louise Newell

Research output: Contribution to journalReview article

58 Citations (Scopus)

Abstract

Antiretroviral therapy can profoundly reduce the risk of mother-to-child transmission (MTCT) of HIV, but the drugs have a relatively short half-life and should thus be administered throughout breast-feeding to optimally prevent postnatal infection of the infant. The potential toxicities and the development of resistance may limit the long-term efficacy of antiretroviral prophylaxis, and a safe and effective active/passive immunoprophylaxis regimen, begun at birth, and potentially overlapping with interpartum or neonatal chemoprophylaxis, would pose an attractive alternative. This review draws on data presented at the Ghent Workshop on prevention of breast milk transmission and on selected issues from a workshop specifically relating to immunoprophylaxis held in Seattle in October 2002. This purpose of this review is to address the scientific rationale for the development of passive (antibody) and active (vaccine) immunization strategies for prevention of MTCT. Data regarding currently or imminently available passive and active immunoprophylaxis products are reviewed for their potential use in neonatal trials within the coming 1-2 years.

Original languageEnglish (US)
Pages (from-to)169-177
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume35
Issue number2
DOIs
StatePublished - Feb 1 2004

Fingerprint

HIV-1
Mothers
Education
Chemoprevention
Human Milk
Breast Feeding
Half-Life
Vaccination
Vaccines
HIV
Parturition
Antibodies
Infection
Pharmaceutical Preparations
Therapeutics

Keywords

  • Immunoprophylaxis
  • Neonates
  • Prevention mother-to-child transmission
  • Vaccines

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Safrit, J. T., Ruprecht, R., Ferrantelli, F., Xu, W., Kitabwalla, M., Van Rompay, K., ... Newell, M. L. (2004). Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes, 35(2), 169-177. https://doi.org/10.1097/00126334-200402010-00012

Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1. / Safrit, Jeffrey T.; Ruprecht, Ruth; Ferrantelli, Flavia; Xu, Weidong; Kitabwalla, Moiz; Van Rompay, Koen; Marthas, Marta; Haigwood, Nancy; Mascola, John R.; Luzuriaga, Katherine; Jones, Samuel Adeniyi; Mathieson, Bonnie J.; Newell, Marie Louise.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 35, No. 2, 01.02.2004, p. 169-177.

Research output: Contribution to journalReview article

Safrit, JT, Ruprecht, R, Ferrantelli, F, Xu, W, Kitabwalla, M, Van Rompay, K, Marthas, M, Haigwood, N, Mascola, JR, Luzuriaga, K, Jones, SA, Mathieson, BJ & Newell, ML 2004, 'Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1', Journal of Acquired Immune Deficiency Syndromes, vol. 35, no. 2, pp. 169-177. https://doi.org/10.1097/00126334-200402010-00012
Safrit JT, Ruprecht R, Ferrantelli F, Xu W, Kitabwalla M, Van Rompay K et al. Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1. Journal of Acquired Immune Deficiency Syndromes. 2004 Feb 1;35(2):169-177. https://doi.org/10.1097/00126334-200402010-00012
Safrit, Jeffrey T. ; Ruprecht, Ruth ; Ferrantelli, Flavia ; Xu, Weidong ; Kitabwalla, Moiz ; Van Rompay, Koen ; Marthas, Marta ; Haigwood, Nancy ; Mascola, John R. ; Luzuriaga, Katherine ; Jones, Samuel Adeniyi ; Mathieson, Bonnie J. ; Newell, Marie Louise. / Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1. In: Journal of Acquired Immune Deficiency Syndromes. 2004 ; Vol. 35, No. 2. pp. 169-177.
@article{4bdc9847b174421e941f07e882ed70b4,
title = "Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1",
abstract = "Antiretroviral therapy can profoundly reduce the risk of mother-to-child transmission (MTCT) of HIV, but the drugs have a relatively short half-life and should thus be administered throughout breast-feeding to optimally prevent postnatal infection of the infant. The potential toxicities and the development of resistance may limit the long-term efficacy of antiretroviral prophylaxis, and a safe and effective active/passive immunoprophylaxis regimen, begun at birth, and potentially overlapping with interpartum or neonatal chemoprophylaxis, would pose an attractive alternative. This review draws on data presented at the Ghent Workshop on prevention of breast milk transmission and on selected issues from a workshop specifically relating to immunoprophylaxis held in Seattle in October 2002. This purpose of this review is to address the scientific rationale for the development of passive (antibody) and active (vaccine) immunization strategies for prevention of MTCT. Data regarding currently or imminently available passive and active immunoprophylaxis products are reviewed for their potential use in neonatal trials within the coming 1-2 years.",
keywords = "Immunoprophylaxis, Neonates, Prevention mother-to-child transmission, Vaccines",
author = "Safrit, {Jeffrey T.} and Ruth Ruprecht and Flavia Ferrantelli and Weidong Xu and Moiz Kitabwalla and {Van Rompay}, Koen and Marta Marthas and Nancy Haigwood and Mascola, {John R.} and Katherine Luzuriaga and Jones, {Samuel Adeniyi} and Mathieson, {Bonnie J.} and Newell, {Marie Louise}",
year = "2004",
month = "2",
day = "1",
doi = "10.1097/00126334-200402010-00012",
language = "English (US)",
volume = "35",
pages = "169--177",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1

AU - Safrit, Jeffrey T.

AU - Ruprecht, Ruth

AU - Ferrantelli, Flavia

AU - Xu, Weidong

AU - Kitabwalla, Moiz

AU - Van Rompay, Koen

AU - Marthas, Marta

AU - Haigwood, Nancy

AU - Mascola, John R.

AU - Luzuriaga, Katherine

AU - Jones, Samuel Adeniyi

AU - Mathieson, Bonnie J.

AU - Newell, Marie Louise

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Antiretroviral therapy can profoundly reduce the risk of mother-to-child transmission (MTCT) of HIV, but the drugs have a relatively short half-life and should thus be administered throughout breast-feeding to optimally prevent postnatal infection of the infant. The potential toxicities and the development of resistance may limit the long-term efficacy of antiretroviral prophylaxis, and a safe and effective active/passive immunoprophylaxis regimen, begun at birth, and potentially overlapping with interpartum or neonatal chemoprophylaxis, would pose an attractive alternative. This review draws on data presented at the Ghent Workshop on prevention of breast milk transmission and on selected issues from a workshop specifically relating to immunoprophylaxis held in Seattle in October 2002. This purpose of this review is to address the scientific rationale for the development of passive (antibody) and active (vaccine) immunization strategies for prevention of MTCT. Data regarding currently or imminently available passive and active immunoprophylaxis products are reviewed for their potential use in neonatal trials within the coming 1-2 years.

AB - Antiretroviral therapy can profoundly reduce the risk of mother-to-child transmission (MTCT) of HIV, but the drugs have a relatively short half-life and should thus be administered throughout breast-feeding to optimally prevent postnatal infection of the infant. The potential toxicities and the development of resistance may limit the long-term efficacy of antiretroviral prophylaxis, and a safe and effective active/passive immunoprophylaxis regimen, begun at birth, and potentially overlapping with interpartum or neonatal chemoprophylaxis, would pose an attractive alternative. This review draws on data presented at the Ghent Workshop on prevention of breast milk transmission and on selected issues from a workshop specifically relating to immunoprophylaxis held in Seattle in October 2002. This purpose of this review is to address the scientific rationale for the development of passive (antibody) and active (vaccine) immunization strategies for prevention of MTCT. Data regarding currently or imminently available passive and active immunoprophylaxis products are reviewed for their potential use in neonatal trials within the coming 1-2 years.

KW - Immunoprophylaxis

KW - Neonates

KW - Prevention mother-to-child transmission

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=9144262305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144262305&partnerID=8YFLogxK

U2 - 10.1097/00126334-200402010-00012

DO - 10.1097/00126334-200402010-00012

M3 - Review article

VL - 35

SP - 169

EP - 177

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 2

ER -